| Financial Year |
March 31 2023 |
| Monetary Funds |
1,206,718,782.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
426,280.50 |
| Accounts Receivable |
310,852,064.08 |
| Advances to Suppliers |
373,258,421.81 |
| Other Receivables |
44,291,426.78 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,514,321,354.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,822,193.29 |
| Total Current Assets |
3,493,690,523.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
189,152,028.68 |
| Investment Properties |
41,573,001.17 |
| Fixed Assetes |
4,419,631,712.34 |
| Under-construction Projects |
23,685,190.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
337,279,522.15 |
| R&D expenses |
-- |
| Goodwill |
18,279,747.20 |
| Long-Term Deferred and Prepaid Expenses |
657,834,099.48 |
| Deferred Income Tax Assets |
18,853,959.48 |
| Other Non-Current Assets |
5,982,389.31 |
| Sub-Total of Non-Current Assets |
8,434,600,507.88 |
| Total Assets |
11,928,291,031.22 |
| Short-Term Loans |
871,357,566.80 |
| Trading Financial liabilities |
-- |
| Notes Payable |
143,224,247.54 |
| Accounts Payable |
1,991,179,774.85 |
| Accounts Received In Advance |
1,624,599.09 |
| Employee Compensation Payable |
47,431,589.18 |
| Taxes Payable |
26,806,866.70 |
| Interest Payable |
-- |
| Dividend Payable |
903,803.18 |
| Other payables |
512,609,497.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
402,746,523.24 |
| Other Current Liabilities |
256,669,466.16 |
| Sub-Total of Current Liabilities |
6,572,737,307.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
58,969,788.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,524,366,132.29 |
| Total Liabilities |
9,097,103,439.30 |
| Paid-In Capital(Or Share Stock) |
681,021,500.00 |
| Capital Surplus |
916,817,273.07 |
| Surplus Reserve |
447,360,182.23 |
| LESS:Treasury Stock |
74,976,042.00 |
| Undistributed Profits |
802,324,801.72 |
| Minority Stockholder's Interest |
58,777,651.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,772,409,940.02 |
| Owner's Equity（Stockholder's Equity） |
2,831,187,591.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,928,291,031.22 |
